EyePoint, Inc. (EYPT) vs Ocugen, Inc. (OCGN)
EyePoint, Inc. and Ocugen, Inc. are both Biotechnology companies. EyePoint, Inc. and Ocugen, Inc. are of similar size ($339.1M and $324.2M). Ocugen, Inc. grew revenue faster over the last twelve months: −3.66% against −94.6%. Ocugen, Inc. has the higher net margin (−1,786.3% vs −10,998.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Ocugen, Inc. leads on 13 and EyePoint, Inc. on 2.
Valuation
Profitability
| Metric | EYPT | OCGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 41.75% | 100.00% | 65.16% |
| Operating margin | (11,369.30%) | (1,504.43%) | 0.00% |
| Net margin | (10,998.67%) | (1,786.27%) | 0.00% |
| Free cash flow margin | (9,724.68%) | (1,332.36%) | 0.00% |
| Return on equity | (148.70%) | 1,211.66% | (57.72%) |
| Return on assets | (115.86%) | (92.03%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack